Your browser doesn't support javascript.
loading
Efficient Vascular and Neural Engraftment of Stem Cell-Derived Islets.
Thorngren, Julia; Brboric, Anja; Vasylovska, Svitlana; Hjelmqvist, Daisy; Westermark, Gunilla T; Saarimäki-Vire, Jonna; Kvist, Jouni; Balboa, Diego; Otonkoski, Timo; Carlsson, Per-Ola; Lau, Joey.
Affiliation
  • Thorngren J; Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden.
  • Brboric A; Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden.
  • Vasylovska S; Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden.
  • Hjelmqvist D; Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden.
  • Westermark GT; Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden.
  • Saarimäki-Vire J; Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Kvist J; Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Balboa D; Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Otonkoski T; Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Carlsson PO; Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Lau J; Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden.
Diabetes ; 73(7): 1127-1139, 2024 Jul 01.
Article in En | MEDLINE | ID: mdl-38603470
ABSTRACT
Pluripotent stem cell-derived islets (SC-islets) have emerged as a new source for ß-cell replacement therapy. The function of human islet transplants is hampered by excessive cell death posttransplantation; contributing factors include inflammatory reactions, insufficient revascularization, and islet amyloid formation. However, there is a gap in knowledge of the engraftment process of SC-islets. In this experimental study, we investigated the engraftment capability of SC-islets at 3 months posttransplantation and observed that cell apoptosis rates were lower but vascular density was similar in SC-islets compared with human islets. Whereas the human islet transplant vascular structures were a mixture of remnant donor endothelium and ingrowing blood vessels, the SC-islets contained ingrowing blood vessels only. Oxygenation in the SC-islet grafts was twice as high as that in the corresponding grafts of human islets, suggesting better vascular functionality. Similar to the blood vessel ingrowth, reinnervation of the SC-islets was four- to fivefold higher than that of the human islets. Both SC-islets and human islets contained amyloid at 1 and 3 months posttransplantation. We conclude that the vascular and neural engraftment of SC-islets are superior to those of human islets, but grafts of both origins develop amyloid, with potential long-term consequences.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Islets of Langerhans Transplantation / Islets of Langerhans Limits: Animals / Humans / Male Language: En Journal: Diabetes Year: 2024 Document type: Article Affiliation country: Suecia Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Islets of Langerhans Transplantation / Islets of Langerhans Limits: Animals / Humans / Male Language: En Journal: Diabetes Year: 2024 Document type: Article Affiliation country: Suecia Country of publication: Estados Unidos